We selected five NRLs to observe the difference in relative expression between glioma and non-tumor brain tissues, including LOXL1-AS1, CRNDE, FAM181A-AS1, SNAI3-AS1, and LINC00641. This evidence concerns the gene FAM181A and central nervous system cancer.